IL-20RB mRNA was significantly elevated in NSCLC tumors and protein levels of the receptors IL-20RB and IL-22R1 were significantly increased in NSCLC patient tumors. This evidence concerns the gene IL22RA1 and non-small cell lung carcinoma.